Clinical evaluation of the topical use of propolis in recurrent minor aphthous ulceration

Authors

  • Mônica A. Lotufo
  • Celso A. L. Júnior
  • Mario T. Shimizu
  • Renata Cabral
  • Esther G. Birman

DOI:

https://doi.org/10.14295/bds.2005.v8i3.327

Abstract

Our purpose was to evaluate the therapeutic effects of a natural product (propolis) on recurrent aphthous ulceration (RAU) of the minor type regarding the number of lesions, their duration and frequency of recurrence. Seventy patients with RAU composed the study group who were examined according to pre-established criteria. Forty patients presenting with RAU (mean age 38.5 years; 25 women and 15 men) were selected and medicated during the recurrence of their lesions using a purified propolis solution in a 5%propyleneglycol vehicle. Patients applied the topical solution three times a day from the first premonitory sign of RAU appearance and also during episodes of recurrence for a period of one year. A statistically significant reduction was observed in the number, frequency and duration of the lesions (p≤ 0.01). The natural propolis product utilized in this study for RAU therapy was without any adverse effects and proved beneficial.

Downloads

Download data is not yet available.

Downloads

Published

2010-08-12

How to Cite

1.
Lotufo MA, Júnior CAL, Shimizu MT, Cabral R, Birman EG. Clinical evaluation of the topical use of propolis in recurrent minor aphthous ulceration. BDS [Internet]. 2010 Aug. 12 [cited 2025 Aug. 21];8(3). Available from: https://ojs.ict.unesp.br/index.php/cob/article/view/327

Issue

Vol. 8 No. 3 (2005)

Section

Clinical or Laboratorial Research

License

Brazilian Dental Science uses the Creative Commons (CC-BY 4.0) license, thus preserving the integrity of articles in an open access environment. The journal allows the author to retain publishing rights without restrictions.

=================

COPYRIGHT TRANSFER AND RESPONSIBILITY STATEMENT
 (PDF)

For all articles published in the BDS journal, copyright is retained by the authors. Articles are licensed under an open-access Creative Commons CC BY 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted, provided that the original published version is cited. These conditions allow for maximum use and exposure of the work while ensuring that the authors receive proper credit. All metadata associated with published articles is released under the Creative Commons CC0 Universal Public Domain Dedication.

Before the submission, authors must obtain permission to reproduce any published material (figures, schemes, tables, or any extract of a text) that does not fall into the public domain or for which they do not hold the copyright. Permission should be requested by the authors from the copyright holder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyright holder).

The authors hereby attest that the study is original and does not present manipulated data, fraud, or plagiarism. All names listed made a significant scientific contribution to the study, are aware of the presented data, and agree with the final version of the manuscript. They assume complete responsibility for the ethical aspects of the study.

This text must be printed and signed by all authors. The scanned version should be submitted as supplemental file during the submission process.